News for Globus Medical, Inc. (GMED)

**media[559702]**

**media[558526]**

Investors need to pay close attention to Globus Medical (GMED) stock based on the movements in the options market lately.

We recently compiled a list of the 7 Best Medical Technology Stocks To Buy According To Analysts. In this article, we are going to take a look at where Globus Medical, Inc.

PR NewswireREDWOOD CITY, Calif., March 4, 2025 REDWOOD CITY, Calif., March 4, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device compan

The MedTech sector is crucial in healthcare, which concentrates on the creation of medical devices aimed at enhancing disease prevention, diagnosis, and treatment.

PR NewswireNEW YORK, Feb. 25, 2025 NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following co

PR NewswireMILWAUKEE, Feb. 24, 2025 MILWAUKEE, Feb. 24, 2025 /PRNewswire/ -- The Ademi Firm is investigating Nevro (NYSE: NVRO) for possible breaches of fi

Shares of Globus Medical Inc (GMED) fell 4.56% in mid-day trading on Feb 23. The stock reached an intraday low of $79.50, before recovering slightly to $80.28

Globus Medical Inc (GMED), a leading musculoskeletal technology company, announced its financial results for the fourth quarter and full year ending December 31

GMED's fourth-quarter 2024 performance reflects strong synergies from the NuVasive merger.

Globus Medical, Inc. (NYSE:GMED) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ETCompany ParticipantsBrian Kearns - SVP, Business Development...

While the top- and bottom-line numbers for Globus Medical (GMED) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Globus Medical (GMED) delivered earnings and revenue surprises of 10.53% and 2.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

**media[546164]**

Get a deeper insight into the potential performance of Globus Medical (GMED) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Globus Medical started 2025 on a solid note, but a deal for loss-making Nevro creates some discomfort among investors. Read why I'm neutral on GMED stock.

On December 31, 2024, JANUS HENDERSON GROUP PLC (Trades, Portfolio) executed a strategic transaction involving Globus Medical Inc (GMED). The firm reduced its h

Globus Medical (GMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.